Total N | 132 | 54 | |
Age (years), median (IQR) | 57 (44–63) | 56 (44–66) | 0.95 |
Sex (male) | 54 (41%) | 27 (28%) | 0.87 |
Stem cell transplant | 26 (20%) | 8 (15%) | 0.30 |
Hematologic malignancy | 52 (39%) | 28 (52%) | 0.50 |
Abdominal malignancy | 36 (27%) | 17 (31%) | 1.00 |
Chemo<6 wks | 59 (45%) | 31 (57%) | 0.61 |
Abdominal radiation | 4 (3.0%) | 5 (9.3%) | 0.15 |
Nausea/vmiting | 57 (43%) | 25 (46%) | 0.61 |
Steroids | 18 (14%) | 7 (13%) | 0.65 |
ANC (1000 cells/μL), median (IQR) | 3.5 (2.2–6.1) | 6.0 (1.6–6.2) | 0.004 |
Platelets (1000/mL), median (IQR) | 125 (54–199) | 153 (63–246) | 0.29 |
Length of stay (days), median (IQR) | 5 (2–10) | 8 (6–12) | 0.02 |
ASA class | | | |
I | 0 (0%) | 0 (0%) | 0.04 |
II | 5 (3.8%) | 3 (5.6%) |
III | 92 (69.7%) | 27 (50%) |
IV | 34 (25.8%) | 24 (44%) |
V | 1 (0.8%) | 0 (0%) |